Wiley Matthew T. Insider Trading
Get the latest insider transactions of Wiley Matthew T.. Wiley Matthew T. is Chief Commercial Officer in Menlo Therapeutics Inc. ($MNLO) and Chief Commercial Officer in Foamix Pharmaceuticals Ltd. ($FOMX). Discover the current value of Wiley Matthew T. shares.
Address: C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLTZMAN STREET REHOVOT 7670402Israel
Wiley Matthew T. is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| FOMX | Foamix Pharmaceuticals Ltd. | Chief Commercial Officer | 78,799 | |
| MNLO | VYNE Therapeutics Inc. | Chief Commercial Officer | 114,397 |
Insider Trading Transactions of Wiley Matthew T.
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 6.84 | 2,573 | 17,599 | 114,397 |
| Feb 24 2021 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 27,675 | 0 | 116,970 |
| Feb 24 2021 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 8.33 | 64,575 | 537,910 | 64,575 |
| Feb 24 2021 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 27,675 | 0 | 116,970 |
| Feb 24 2021 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 8.33 | 64,575 | 537,910 | 64,575 |
| Jan 05 2021 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 1.58 | 1,541 | 2,435 | 357,181 |
| Jan 05 2021 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 1.58 | 1,541 | 2,435 | 357,181 |
| Dec 02 2020 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 1.45 | 7,838 | 11,326 | 358,722 |
| Oct 02 2020 | MNLO | VYNE Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 1.66 | 1,541 | 2,558 | 350,884 |
| May 08 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 150,000 | 0 | 353,967 |
| May 08 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 1.95 | 150,000 | 292,500 | 150,000 |
| Apr 07 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 46,394 | 0 | 113,445 |
| Apr 07 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 91,430 | 0 | 204,875 |
| Apr 07 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 1.40 | 908 | 1,271 | 203,967 |
| Apr 02 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 2.68 | 525 | 1,407 | 67,051 |
| Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 0.00 | 35,275 | 0 | 78,799 |
| Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 0.00 | 35,275 | 0 | 78,799 |
| Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 0.00 | 78,799 | 0 | 0 |
| Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Sell | 0.00 | 78,799 | 0 | 0 |
| Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 4.06 | 100,000 | 406,000 | 0 |
| Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 4.06 | 100,000 | 406,000 | 0 |
| Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 4.03 | 96,365 | 388,351 | 0 |
| Mar 11 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 4.03 | 96,365 | 388,351 | 0 |
| Mar 11 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 20,896 | 0 | 20,896 |
| Mar 11 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 46,680 | 0 | 67,576 |
| Mar 11 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 6.86 | 59,240 | 406,386 | 59,240 |
| Mar 11 2020 | MNLO | Menlo Therapeutics Inc. | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 6.81 | 57,086 | 388,756 | 57,086 |
| Feb 24 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 41,299 | 0 | 112,081 |
| Feb 24 2020 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 4.03 | 96,365 | 388,351 | 96,365 |
| Dec 03 2019 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 2.16 | 9,842 | 21,249 | 73,282 |
| Mar 06 2019 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 3.76 | 13,440 | 50,534 | 63,440 |
| Dec 04 2018 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Buy | 0.00 | 50,000 | 0 | 50,000 |
| Dec 04 2018 | FOMX | Foamix Pharmaceuticals Lt ... | Wiley Matthew T. | Chief Commercial Offi ... | Option Exercise | 4.06 | 100,000 | 406,000 | 100,000 |